Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct 3;396(10256):953.
doi: 10.1016/S0140-6736(20)32020-1.

Remdesivir and COVID-19

Affiliations
Comment

Remdesivir and COVID-19

Jessie K Edwards et al. Lancet. .
No abstract available

PubMed Disclaimer

Comment in

  • Remdesivir and COVID-19 - Authors' reply.
    Wang Y, Gu X, Xu J, Cao B, Wang C. Wang Y, et al. Lancet. 2020 Oct 3;396(10256):954. doi: 10.1016/S0140-6736(20)32015-8. Lancet. 2020. PMID: 33010835 Free PMC article. No abstract available.

Comment on

  • Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
    Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Wang Y, et al. Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29. Lancet. 2020. PMID: 32423584 Free PMC article. Clinical Trial.

Similar articles

Cited by

References

    1. Wang Y, Zhang D, Du G. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395:1569–1578. - PMC - PubMed
    1. Cao B, Wang Y, Wen D. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382:1787–1799. - PMC - PubMed
    1. Edwards JK, Cole SR, Westreich D. Age at entry into care, timing of antiretroviral therapy initiation, and 10-year mortality among HIV-seropositive adults in the United States. Clin Infect Dis. 2015;61:1189–1195. - PMC - PubMed